Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction
Presenter: Emmanuel Otabor
Up Next
Presenter: Ibrahim Kamel
More slides +
Presenter: Phuuwadith Wattanachayakul
Presenter: Phuuwadith Wattanachayakul